UNSPSC 51162714: Guaiacol acetate

This classification denotes a topical anti-infective agent and expectorant with the molecular formula C9H10O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K5YN7743HC, chemically known as phenol, 2-methoxy-, 1-acetate, but more generally known as guaiacol acetate, which bears US NIH Compound Identifier 61155. European Medicines Agency schedules guaiacol acetate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14027MIG.

Most nations, for tariff purposes, schedule guaiacol acetate under HS 29095000. SMILES: CC(=O)OC1CCCCC1OC.

UNSPSC 51162714 Guaiacol acetate is a Commodity code that covers specialized chemical compounds used in pharmaceutical and medical applications. However, the recent state and local opportunities tagged under this code do not align with guaiacol acetate procurement; instead, they reflect solicitations for parenteral medical products and naloxone-based harm-reduction supplies. The Washington State Department of Corrections (DOC) is procuring parenteral nutrition solutions, intravenous solutions, and related parenteral products for eight correctional facilities, while Seminole County, Florida is seeking naloxone and drug deactivation systems for community health initiatives. Neither opportunity represents procurement of guaiacol acetate itself, indicating minimal relevant recent activity under this code's actual scope within state and local procurement.

Geographic activity appears limited to Washington and Florida based on the recent record. The Washington State DOC RFQQ (RFQQK13020), due October 7, 2026, is open to small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses under Washington's Chapter 39.19 RCW set-aside framework, with an aspirational 5% Small and Diverse Business Goal and multi-award structure across three regions. The Seminole County IFB for naloxone and drug deactivation systems carried a July 26, 2023 response deadline (now expired) and includes FEMA-potential funding with federal compliance overlay. The mismatch between the code's nominal scope and the work actually being solicited suggests either mistagging in the source data or that guaiacol acetate procurement under this code is not active in current state and local markets.